Willie Muehlhausen

Streamlining electronic clinical outcome assessment and patient-reported outcome processes can aid in decreasing timelines.

Investment in mHealth and the adoption of wearables are significant initiatives that are changing the clinical trial process toward a more patient centered approach. These wearable technology initiatives have the potential to be the most innovative advances in drug development.

Survey uncovers the challenges, myths, and potential useful strategies associated with BYOD adoption.